Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

45-day funding bill OK'd
Fatally shoved an old woman
Post-race altercation
Won’t cover father’s case
Ex-sheriff shoots salesman
'I don't know who we are'
Turkey suicide bombing
Slams House stopgap bill
Fined $87K for rough play
Appeals against polarization
Australia's 'scorching' heat
CN's lottery ticket sales soar
Body found on 5 Freeway
3-day wait to buy guns
S. Korea Sept exports fall
To miss Hornets camp
Spain nightclub fire kills 7
Green suffers ankle injury
Bautista to undergo surgery
Jackpot swells to $1B
Misses another match
Whale capsizes boat, 1 dead
1990 murder victim ID’d
Tests COVID positive
Parasite found in lake
Locked woman in a cell?
Fed agency sues Chipotle
Addresses Tupac's murder
Renaissance tour movie
‘One day at a time'
Becky G embraces heritage
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
109,000 results
Hosted on MSN1mon
UPDATE 1-EU approves Pfizer's RSV vaccine to protect infants and older adults
Aug 24 (Reuters) - The European Commission on Thursday approved U.S. drugmaker Pfizer's vaccine for respiratory syncytial virus (RSV) to protect both babies and older adults in the European Union.
Barron's1mon
EU Authorises Sale Of Vaccine Against RSV In Infants
The EU on Friday authorised the sale of a vaccine to protect infants from respiratory syncytial virus (RSV), a disease that in worst cases can lead to pneumonia and bronchiolitis. The bloc-wide ...
Hebdo Ahram1mon
EU drug watchdog approves first RSV infant vaccine
RSV normally causes mild, cold-like symptoms, but can be serious for infants the elderly, those with weak immune systems and underlying conditions, and is a leading cause of paediatric ...
Hosted on MSN1mon
FDA approves first vaccine to protect newborns from RSV
The US Food and Drug Administration on Monday approved the first vaccine that protects newborns from respiratory syncytial virus, known as RSV. The vaccine, made by Pfizer, is given to mothers ...
2don MSN
These Are the RSV Vaccine Side Effects in Older Adults, According to Doctors
The FDA notes that, in one of the clinical trials for the vaccine, two of the participants developed acute disseminated encephalomyelitis (ADEM), a rare type of inflammation that affects the brain and ...
Nasdaq1mon
EU approves Pfizer's RSV vaccine to protect infants and older adults
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Reuters, the news and media division of Thomson Reuters, is ...
Yahoo News1mon
EU authorises sale of vaccine against RSV in infants
The EU on Friday authorised the sale of a vaccine to protect infants from respiratory syncytial virus (RSV), a disease that in worst cases can lead to pneumonia and bronchiolitis. The bloc-wide ...
News 12 Networks1mon
FDA approves first vaccine to protect infants from RSV
The FDA has approved the first vaccine to protect infants against RSV, a respiratory virus that can be deadly. The new shot, from Pfizer, will be given to pregnant mothers. In clinical trials, it ...
AOL.co.uk1mon
EU approves Pfizer's RSV vaccine to protect infants and older adults
(Reuters) -The European Commission on Thursday approved U.S. drugmaker Pfizer's vaccine for respiratory syncytial virus (RSV) to protect both babies and older adults in the European Union.
KCCI Des Moines1mon
FDA approves first vaccine to protect newborns from RSV
The FDA has approved the first long acting drug to protect infants and toddlers from the respiratory virus known as RSV. The antibody preventive therapy called, was approved Monday for injection ...
AOL1mon
FDA approves first vaccine to protect newborns from RSV
Still, the vaccine, given from 32 to 36 weeks of gestational age, does not provide long-term protection. For the first three months after birth, the vaccine was 82% effective at preventing severe ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices